107 related articles for article (PubMed ID: 28523414)
1. Fully navigated 3 T proton magnetic resonance spectroscopy of liver metastases with inner-volume saturation.
Reischauer C; Hock A; Kolokythas O; Binkert CA; Gutzeit A
Abdom Radiol (NY); 2017 Nov; 42(11):2615-2622. PubMed ID: 28523414
[TBL] [Abstract][Full Text] [Related]
2. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
3. Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by
Ter Voert EEGW; Heijmen L; van Asten JJA; Wright AJ; Nagtegaal ID; Punt CJA; de Wilt JHW; van Laarhoven HWM; Heerschap A
NMR Biomed; 2019 Jan; 32(1):e4035. PubMed ID: 30457686
[TBL] [Abstract][Full Text] [Related]
4. Retrospective phase-based gating for cardiac proton spectroscopy with fixed scan time.
Gastl M; Peereboom SM; Fuetterer M; Boenner F; Kelm M; Manka R; Kozerke S
J Magn Reson Imaging; 2019 Dec; 50(6):1973-1981. PubMed ID: 31125172
[TBL] [Abstract][Full Text] [Related]
5. Navigator based respiratory gating during acquisition and preparation phases for proton liver spectroscopy at 3 T.
Hock A; Valkovič L; Geier A; Kuntzen T; Boesiger P; Henning A
NMR Biomed; 2014 Mar; 27(3):348-55. PubMed ID: 24591124
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (∆CCC) in primary malignant hepatic tumors.
Zhang L; Zhao X; Ouyang H; Wang S; Zhou C
Cancer Imaging; 2016 Aug; 16(1):25. PubMed ID: 27549094
[TBL] [Abstract][Full Text] [Related]
7. Multiple breath-hold proton spectroscopy of human liver at 3T: Relaxation times and concentrations of glycogen, choline, and lipids.
Weis J; Kullberg J; Ahlström H
J Magn Reson Imaging; 2018 Feb; 47(2):410-417. PubMed ID: 28419608
[TBL] [Abstract][Full Text] [Related]
8. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.
Wu B; Peng WJ; Wang PJ; Gu YJ; Li WT; Zhou LP; Tang F; Zhong GM
Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla.
Fischbach F; Schirmer T; Thormann M; Freund T; Ricke J; Bruhn H
Eur Radiol; 2008 Nov; 18(11):2549-58. PubMed ID: 18491103
[TBL] [Abstract][Full Text] [Related]
10. [In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].
Müller C; Hübner F; Bisdas S; Herzog C; Hammerstingl RM; Ackermann H; Vorbuchner M; Vogl TJ
Rofo; 2006 Nov; 178(11):1128-36. PubMed ID: 17128381
[TBL] [Abstract][Full Text] [Related]
11. [Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma].
Beer M; Winkelmann V; Becker JC; Terheyden P; Stenzel M; Bröcker EB; Hahn D; Köstler H
Rofo; 2009 Jan; 181(1):60-6. PubMed ID: 19085691
[TBL] [Abstract][Full Text] [Related]
12. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
13. In vivo H1 MR spectroscopy using 3 Tesla to investigate the metabolic profiles of joint fluids in different types of knee diseases.
Jin W; Woo DC; Jahng GH
J Appl Clin Med Phys; 2016 Mar; 17(2):561-572. PubMed ID: 27074491
[TBL] [Abstract][Full Text] [Related]
14. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in Wistar rat.
Zhao WD; Guan S; Zhou KR; Li H; Peng WJ; Tang F; Chen ZW
J Cancer Res Clin Oncol; 2005 Sep; 131(9):597-602. PubMed ID: 15991046
[TBL] [Abstract][Full Text] [Related]
18. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
19. Navigated single-voxel proton spectroscopy of the human liver.
Tyszka JM; Silverman JM
Magn Reson Med; 1998 Jan; 39(1):1-5. PubMed ID: 9438429
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
